CPF III-A PT SPV, LLC's Form 4/A amendment
AmendedP3 Health Partners Inc. (PIII) · filed Sep 10, 2024
- Accession no.
- 0001213900-24-077451
- Filed
- Sep 10, 2024, 5:55 PM ET
- Rule 10b5-1 plan
- Not checked
- Original filed
- Sep 13, 2023
This filing lists no transactions. It carries over 3 transactions from the original filing that it did not restate. Open-market purchases total $685.0K.
This amendment restates part of 0001062993-23-018941 (filed Oct 4, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| CPF III-A PT SPV, LLCCIK 0001975600 | 10% Owner |
| CPF III PT SPV, LLCCIK 0001975601 | 10% Owner |
| Chicago Pacific Founders UGP III, LLCCIK 0001975658 | 10% Owner |
| Chicago Pacific Founders GP III, L.P.CIK 0001975828 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001062993-23-018941 (filed Oct 4, 2023).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2023 | Class A Common Stock | PPurchaseAcquired | +90,000 | $2.34F2 | +$210,222 | 49,575,442 | Indirect | |
| Sep 12, 2023 | Class A Common Stock | PPurchaseAcquired | +90,000 | $2.63F4 | +$236,520 | 49,665,442 | Indirect | |
| Sep 13, 2023 | Class A Common Stock | PPurchaseAcquired | +90,000 | $2.65F5 | +$238,221 | 49,755,442 | Indirect |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.20 to $2.40, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.36 to $2.9366, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 4.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.52 to $2.84, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 5.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On September 13, 2023, the reporting person filed a Form 4 which inadvertently omitted 90,000 shares and resulted in an incorrect number of shares in Column 5 of Table I. The omission effected the number of shares reported in Column 5 of Table I of each of the reporting person's subsequent filings on Form 4.
- F2
Chicago Pacific Founders UGP, III LLC ("UGP III") is the general partner of Chicago Founders GP III, LP ("GP III"), the general partner of each of SPV III and SPV III -A. As a result, UGP III has the power to vote and dispose of the Issuer's securities held by SPV III and SPV III -A (the "Underlying Securities"). Each of UGP III and GP III disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities.